Design of a multicohort evaluation of statin adherence after the start of 2 cost-sharing policies Sebastian Schneeweiss, et al. Circulation 2007;115:2128-35.

Slides:

Advertisements

Similar presentations

The Impact of Cost-Sharing on Adherence to Antihypertensive Drugs for Low and High Adherers Jean Yoon UCLA Department of Health Services.

Advertisements

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: /NEJMSA Niteesh K. Choudhry,

Inappropriate clopidogrel adherence explains stent related adverse outcomes Leonardo Tamariz, MD, MPH University of Miami.

Slide Source: Lipids Online Slide Library Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT): Design Cannon CP.

RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.

Sattar N, et al. Lancet 2010;375: Flow diagram of literature search to identify randomised placebo-controlled and standard care-controlled statin.

Clinical Trial Results. org Relationship Between Adherence to Evidence- Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction.

RALES: Randomized Aldactone Evaluation Study Purpose To determine whether the aldosterone antagonist spironolactone reduces mortality in patients with.

Design of a multicohort evaluation of statin adherence after the start of 2 cost-sharing policies Sebastian Schneeweiss, et al. Circulation 2007;115:

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.

David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

2007May221 Journal Club for Analysis of Complex Datasets Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic,

Shalev V, et al. Arch Intern Med 2009; 169:

Baseline Characteristics of Patients Referred for Stress Myocardial Perfusion Testing by Erectile Function Classification James K. Min, et al, Arch Intern.

ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:

Transparency in the Use of Propensity Score Methods

Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.

Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Fixed-Dose Combination Strategy on Adherence.

Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,

Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.

Search strategy and results Amir Kashani, et al. Circulation. 2006;114:

Discontinuation of medication after nonfatal event: MI

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,

Volume 122, Pages 1-11 (January 2017)

Baseline Characteristics of 167 Patients Randomly Assigned to Either Placebo or Extended-Release Niacin Allen J. Taylor et al. Circulation 2004; 110:

Canagliflozin: Real World Experience

Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery.

What about CMR in patients with acute MI?

FATS- Familial Atherosclerosis Treatment Study

Neil J. Stone et al. JACC 2014;63:

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load by Steven G. Deeks, Christina.

Diabetes hazard rates by number of visits with reported statin use.

PREMIER: Rate of hypertension at 18 months

Annals of Internal Medicine • Vol. 167 No. 12 • 19 December 2017

Atorvastatin for Reduction of Myocardial Damage During Angioplasty

Hammoud et al. Am J Nephrol 2016;44: (DOI: / )

Selmer R, et al. Br J Clin Pharmacol 2009;67:355-62

Belinda Gray et al. JCHF 2013;1:

End point Fenoldopam, n (%) Dopamine, n (%) p

Q.A. Truong et al. Circ Cardiovasc Qual Outcomes 2011;4:

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Patient characteristics in the entire study group

Characteristics of elderly patients prescribed statins after acute myocardial infarction (AMI) in Quebec, Ontario and British Columbia - Part I Zheng.

Figure 2 JCV index JCV index (A) Fifty samples of natalizumab-treated patients with multiple sclerosis were assessed twice for their anti-JCV antibody.

Flow of Patients Through the Trial

Baseline Characteristics According to Sex

(A and B) Changes in the apnoea hypopnoea index (AHI) and 3% oxygen desaturation index (ODI) from baseline to treatment titration and 3 months of therapy:

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Perreault S, et al. Eur J Clin Pharmacol 2009 Jun 16 [Epub]

Characteristics of Large Randomized Controlled Statin Trials Included in the Present Analysis Alawi A. et al. JACC 2008 Aug 20 [Epub ahead of print]

Baseline Characteristics by hs-CRP

(A) Absolute and (B) change from baseline in 6 min walk distance over time for all patients and by Down syndrome status. (A) Absolute and (B) change from.

The 6MWT results showing improvement from baseline at 1, 6 and 12 months in patients receiving an implant (mean±SE of mean). The 6MWT results showing improvement.

Box plot of acquisition times across the various study cohorts.

Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:

Baseline characteristics of study population

Headache frequency after medication withdrawal in medication-overuse headache. Headache frequency after medication withdrawal in medication-overuse headache.

John P. Boehmer et al. JCHF 2017;5:

Crude and adjusted HbA1c change by medication adherence group (proportion of days covered (PDC)) by linear regression, controlling for age, age2, gender,

Kaplan-Meier plot presenting PFS for patients with BRAFV600-mutated ctDNA at first visit (

Distribution of percent consistent facility aspirin use.

Waterfall plot showing the relative change in median tumor FES uptake (SUVcor) in individual patients at the second scan compared with baseline. Waterfall.

Changes over time in DAS 28 (A), SLEDAI (B), glucocorticoid dose (C) and EULAR response (D) in patients with rhupus treated by anti-TNF-α. Box plot (median,

Two run charts showing the effects of Plan, Do, Study, Act cycles on 24-hour Electronic Patient Records venous thromboembolism (EPR VTE) risk assessment.

A 63-year-old female with lung adenocarcinoma treated with nivolumab, who experienced pseudoprogression. A 63-year-old female with lung adenocarcinoma.

Genomic determinants of response to cytotoxic chemotherapy.

Fig 2 Predicted probabilities of being in each of the five change in substance use categories (change from baseline in average daily amount of main substance)

Baseline New York Heart Association functional class (NYHA FC) predicts survival in patients with pulmonary hypertension using infused epoprostenol therapy.

Presentation transcript:

Design of a multicohort evaluation of statin adherence after the start of 2 cost-sharing policies Sebastian Schneeweiss, et al. Circulation 2007;115:2128-35

Baseline Covariates for 3 Cohorts of New Statin Users Sebastian Schneeweiss, et al. Circulation 2007;115:2128-35

Adherence for the baseline, copayment, and coinsurance cohorts Adherence for the baseline, copayment, and coinsurance cohorts showing a sudden decline in adherence  100 days (equal to the median prescription supply) after the policy changes. Adherence was measured as the proportion of patients with >80% of days covered during each month. Unadjusted proportions were plotted. Sebastian Schneeweiss, et al. Circulation 2007;115:2128-35

New initiations of statin therapy after AMI at baseline and under a copayment and coinsurance policy New initiation of statins was defined as not having used a statin for at least 6 months before the index MI. Q indicates quarter. Sebastian Schneeweiss, et al. Circulation 2007;115:2128-35

Independent Risk Factors for Discontinuing Statin Therapy, From Logistic Regression Analysis* Sebastian Schneeweiss, et al. Circulation 2007;115:2128-35